Available options for treatment of interferon nonresponders

American Journal of Medicine

Volumn 107, Issue 6 SUPPL. 2, 1999, Pages 67-70

  Bacon, Bruce R ^a  

^a Div of Gastroenterol and Hepatol   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ALPHA2B INTERFERON; CONSENSUS INTERFERON; RIBAVIRIN; VIRUS RNA;

CHRONIC DISEASE; CONFERENCE PAPER; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MONOTHERAPY; PHLEBOTOMY; PRIORITY JOURNAL; RETREATMENT;

EID: 0033372623     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(99)00386-1     Document Type: Conference Paper

References (11)

1. National Institutes of Health Consensus Development Conference Panel Statement: Management of Hepatitis C. March 24-26, 1997;15(3).
2. Van Thiel D.H., Friedlander L., Molloy P.J., et al. Retreatment of hepatitis C interferon non-responders with larger dose of interferon with and without phlebotomy. Hepato-Gastroenterology. 43:1996;1557-1561.
3. Lindsay K.L., Davis G.L., Schiff E.R., et al. Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C a randomized multicenter trial. Hepatitis interventional therapy group . Hepatology. 25:1996;1034-1040.
4. Heathcote E.J., Keefe E.B., Lee S.S., et al. Re-treatment of chronic hepatitis C with consensus interferon. Hepatology. 27:1998;1136-1143.
5. Bacon B.R., Rauscher J.A., Smith-Wilkaitis N.L., et al. Interferon-ribavirin combination sustained response in previous monotherapy non-responders . Hepatology. 30:1999;372A. Abstract.
6. Olynyk J.K., Reddy K.R., Di Bisceglie A.M., et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology. 108:1995;1104-1109.
7. Sutnic A.I., Blumberg B.S., Lustbader E.D. Elevated serum iron levels and persistent Australia antigen (HBsAg). Ann Intern Med. 81:1974;855-856.
8. Van Thiel D.H., Friedlander L., Fagivoli S., et al. Response to interferon α therapy is influenced by the iron content of the liver. J Hepatology. 20:1994;410-415.
9. Hayashi H., Takikawa T., Nishimura N., et al. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol. 89:1994;986-988.
10. Di Bisceglie A.M., Bonkovsky H.L., Krawitt E.L., et al. Iron reduction therapy in chronic hepatitis C. Hepatology. 26:1997;214A. Abstract.
11. Poynard T., Bedossa P., Chevallier M., et al. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A; non-B hepatitis. N Engl J Med. 332:1995;1457-1462.